222 related articles for article (PubMed ID: 19339660)
1. Differential regulation of receptor activation and agonist selectivity by highly conserved tryptophans in the nicotinic acetylcholine receptor binding site.
Williams DK; Stokes C; Horenstein NA; Papke RL
J Pharmacol Exp Ther; 2009 Jul; 330(1):40-53. PubMed ID: 19339660
[TBL] [Abstract][Full Text] [Related]
2. Reversal of agonist selectivity by mutations of conserved amino acids in the binding site of nicotinic acetylcholine receptors.
Horenstein NA; McCormack TJ; Stokes C; Ren K; Papke RL
J Biol Chem; 2007 Feb; 282(8):5899-909. PubMed ID: 17189260
[TBL] [Abstract][Full Text] [Related]
3. Positive modulation of alpha7 nAChR responses in rat hippocampal interneurons to full agonists and the alpha7-selective partial agonists, 4OH-GTS-21 and S 24795.
López-Hernández GY; Thinschmidt JS; Morain P; Trocme-Thibierge C; Kem WR; Soti F; Papke RL
Neuropharmacology; 2009 Mar; 56(4):821-30. PubMed ID: 19705574
[TBL] [Abstract][Full Text] [Related]
4. Molecular dissection of tropisetron, an alpha7 nicotinic acetylcholine receptor-selective partial agonist.
Papke RL; Schiff HC; Jack BA; Horenstein NA
Neurosci Lett; 2005 Apr; 378(3):140-4. PubMed ID: 15781147
[TBL] [Abstract][Full Text] [Related]
5. Comparative pharmacology of rat and human alpha7 nAChR conducted with net charge analysis.
Papke RL; Porter Papke JK
Br J Pharmacol; 2002 Sep; 137(1):49-61. PubMed ID: 12183330
[TBL] [Abstract][Full Text] [Related]
6. The nicotinic acetylcholine receptors of zebrafish and an evaluation of pharmacological tools used for their study.
Papke RL; Ono F; Stokes C; Urban JM; Boyd RT
Biochem Pharmacol; 2012 Aug; 84(3):352-65. PubMed ID: 22580045
[TBL] [Abstract][Full Text] [Related]
7. Analysis of 3-(4-hydroxy, 2-Methoxybenzylidene)anabaseine selectivity and activity at human and rat alpha-7 nicotinic receptors.
Meyer EM; Kuryatov A; Gerzanich V; Lindstrom J; Papke RL
J Pharmacol Exp Ther; 1998 Dec; 287(3):918-25. PubMed ID: 9864273
[TBL] [Abstract][Full Text] [Related]
8. The unique α4+/-α4 agonist binding site in (α4)3(β2)2 subtype nicotinic acetylcholine receptors permits differential agonist desensitization pharmacology versus the (α4)2(β2)3 subtype.
Eaton JB; Lucero LM; Stratton H; Chang Y; Cooper JF; Lindstrom JM; Lukas RJ; Whiteaker P
J Pharmacol Exp Ther; 2014 Jan; 348(1):46-58. PubMed ID: 24190916
[TBL] [Abstract][Full Text] [Related]
9. Rhesus monkey alpha7 nicotinic acetylcholine receptors: comparisons to human alpha7 receptors expressed in Xenopus oocytes.
Papke RL; McCormack TJ; Jack BA; Wang D; Bugaj-Gaweda B; Schiff HC; Buhr JD; Waber AJ; Stokes C
Eur J Pharmacol; 2005 Nov; 524(1-3):11-8. PubMed ID: 16266703
[TBL] [Abstract][Full Text] [Related]
10. The structural basis for GTS-21 selectivity between human and rat nicotinic alpha7 receptors.
Stokes C; Papke JK; Horenstein NA; Kem WR; McCormack TJ; Papke RL
Mol Pharmacol; 2004 Jul; 66(1):14-24. PubMed ID: 15213292
[TBL] [Abstract][Full Text] [Related]
11. alpha7 receptor-selective agonists and modes of alpha7 receptor activation.
Papke RL; Meyer E; Nutter T; Uteshev VV
Eur J Pharmacol; 2000 Mar; 393(1-3):179-95. PubMed ID: 10771012
[TBL] [Abstract][Full Text] [Related]
12. Modulation of spontaneous hippocampal synaptic events with 5-hydroxyindole, 4OH-GTS-21, and rAAV-mediated alpha7 nicotinic receptor gene transfer.
Thinschmidt JS; López-Hernández GY; Ren K; King MA; Meyer EM; Papke RL
Brain Res; 2008 Apr; 1203():51-60. PubMed ID: 18321476
[TBL] [Abstract][Full Text] [Related]
13. Activation and inhibition of native neuronal alpha-bungarotoxin-sensitive nicotinic ACh receptors.
Uteshev VV; Meyer EM; Papke RL
Brain Res; 2002 Sep; 948(1-2):33-46. PubMed ID: 12383953
[TBL] [Abstract][Full Text] [Related]
14. Differential α4(+)/(-)β2 Agonist-binding Site Contributions to α4β2 Nicotinic Acetylcholine Receptor Function within and between Isoforms.
Lucero LM; Weltzin MM; Eaton JB; Cooper JF; Lindstrom JM; Lukas RJ; Whiteaker P
J Biol Chem; 2016 Jan; 291(5):2444-59. PubMed ID: 26644472
[TBL] [Abstract][Full Text] [Related]
15. Interaction of benzylidene-anabaseine analogues with agonist and allosteric sites on muscle nicotinic acetylcholine receptors.
Arias HR; Xing H; Macdougall K; Blanton MP; Soti F; Kem WR
Br J Pharmacol; 2009 May; 157(2):320-30. PubMed ID: 19338581
[TBL] [Abstract][Full Text] [Related]
16. Modeling subtype-selective agonists binding with alpha4beta2 and alpha7 nicotinic acetylcholine receptors: effects of local binding and long-range electrostatic interactions.
Huang X; Zheng F; Chen X; Crooks PA; Dwoskin LP; Zhan CG
J Med Chem; 2006 Dec; 49(26):7661-74. PubMed ID: 17181149
[TBL] [Abstract][Full Text] [Related]
17. Structural and functional studies of the modulator NS9283 reveal agonist-like mechanism of action at α4β2 nicotinic acetylcholine receptors.
Olsen JA; Ahring PK; Kastrup JS; Gajhede M; Balle T
J Biol Chem; 2014 Sep; 289(36):24911-21. PubMed ID: 24982426
[TBL] [Abstract][Full Text] [Related]
18. The additional ACh binding site at the α4(+)/α4(-) interface of the (α4β2)2α4 nicotinic ACh receptor contributes to desensitization.
Benallegue N; Mazzaferro S; Alcaino C; Bermudez I
Br J Pharmacol; 2013 Sep; 170(2):304-16. PubMed ID: 23742319
[TBL] [Abstract][Full Text] [Related]
19. Electrophysiological perspectives on the therapeutic use of nicotinic acetylcholine receptor partial agonists.
Papke RL; Trocmé-Thibierge C; Guendisch D; Al Rubaiy SA; Bloom SA
J Pharmacol Exp Ther; 2011 May; 337(2):367-79. PubMed ID: 21285282
[TBL] [Abstract][Full Text] [Related]
20. Discovery of an intrasubunit nicotinic acetylcholine receptor-binding site for the positive allosteric modulator Br-PBTC.
Norleans J; Wang J; Kuryatov A; Leffler A; Doebelin C; Kamenecka TM; Lindstrom J
J Biol Chem; 2019 Aug; 294(32):12132-12145. PubMed ID: 31221718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
